<!DOCTYPE html>
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>

    <!-- Basic Page Needs
  ================================================== -->
	<meta charset="utf-8">
	<title>Times of Pshychiatry</title>
	<meta name="description" content=" |">
	<meta name="medekahealth" content="">
	
    <!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    
    <!-- CSS
  ================================================== -->
	<link rel="stylesheet" href="css/style.css">
    <link rel="stylesheet" href="css/responsive.css">
	
	<!--[if lt IE 8]>
       <div style=' clear: both; text-align:center; position: relative;'>
         <a href="http://windows.microsoft.com/en-US/internet-explorer/products/ie/home?ocid=ie6_countdown_bannercode">
           <img src="http://storage.ie6countdown.com/assets/100/images/banners/warning_bar_0000_us.jpg" border="0" height="42" width="820" alt="You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today." />
        </a>
      </div>
    <![endif]-->
    <!--[if lt IE 9]>
		<script src="js/html5.js"></script>
		<script src="js/css3-mediaqueries.js"></script>
	<![endif]-->
	
	<link href='./images/top.ico' rel='icon' type='image/x-icon'/>
<style type="text/css">
a:hover {
	cursor:pointer; 
}
</style>
<script type="text/javascript">

//SAG scroller demo #1:

var sagscroller1=new sagscroller({
	id:'mysagscroller',
	mode: 'manual' //<--no comma following last option
})

//SAG scroller demo #2:

var sagscroller2=new sagscroller({
	id:'mysagscroller2',
	mode: 'auto',
	pause: 2500,
	animatespeed: 400 //<--no comma following last option
})
     function show(id)
     {
		
        if(document.getElementById(id).style.display == 'none')
        {
              document.getElementById(id).style.display='inline';
			  document.getElementById(id).select();
        }
		else if(document.getElementById(id).style.display == 'inline')
        {
              document.getElementById(id).style.display='none';
        } 
     }
    </script>    
</head>
<body>
<!--------------Header--------------->
<header> 
  <div id="logo"><a href="#"><img src="./images/logo.png"/></a></div>
</header>
<!--------------Navigation--------------->
<nav>
	<ul class="menu">
    	<li><a href="index.html">About TOP</a></li>
		<li><a href="aboutus.html">About us</a></li>
		<li><a href="contact.html">Contact</a></li>
	</ul>
	<div class="minimenu"><div>INDEX</div>
		<select onchange="location=this.value">
        <option></option>
			<option value="Index.html">Home</option>
			<option value="Amisulpride.html">Amisulpride</option>
			<option value="DER.html">Divalproex extended release</option>
			<option value="MBD.html">MetS with bipolar disorder</option>
			<option value="EP.html">Escitalopram</option>
			<option value="ZER.html">Zolpidem extended release</option>
            <option value="SCL.html">Scales</option>
			<option value="GDL.html">Guidelines</option>
			<option value="JC.html">Journal scans</option>
			<option value="CN.html">Conference news</option>
            <option value="PMS.html">Psychiatry medical app</option>
            <option value="BR.html">Book review</option> 
		</select>
	</div>
</nav>
<!--------------Content--------------->
<section id="content">
	<div id="main-content">
		<article>
			<div class="heading">
<div style="background-color:#007945; padding:10px; border-radius:10px;"><h11a>NICE guidelines revise treatment recommendations
for schizophrenia</h11a></div>
				<div class="info"> by Medeka | November 01, 2013</div>
			</div><h12f>Recommendations</h12f>       
			<div class="content">Antipsychotics are the mainstay of treatment for
schizophrenia. They are used for the treatment
of acute episodes, for relapse prevention, and
for symptom reduction. A combination of
antipsychotics and other classes of drugs, such as
anticonvulsants, mood stabilizers, anticholinergics,
antidepressants, and benzodiazepines may
also be used. Antipsychotics are available as
oral, intramuscular (IM), and intravenous (IV)
preparations, or as medium- or long-acting depot
IM preparations.
            <ul>
              <li style="list-style-type:square; color:#007945; font-size:16px"><a href="GDL-IIa.html">
              Initiation of treatment (first episode) </a></li>
<li style="list-style-type:square; color:#007945; font-size:16px"><a href="GDL-IIb.html">Use of oral antipsychotic medication</a></li>
<li style="list-style-type:square; color:#007945; font-size:16px"><a href="GDL-IIc.html">Acute episode treatment</a></li>
<li style="list-style-type:square; color:#007945; font-size:16px"><a href="GDL-IId.html">Relapse prevention</a></li>
<li style="list-style-type:square; color:#007945; font-size:16px">Treatment-resistant
schizophrenia</li>
Various interventions can be considered in patients
with schizophrenia who have inadequate or no
response to pharmacological or psychological
treatment:
<ol style="list-style:upper-roman; font-size:14px">
<li>Review the diagnosis</li>
<li>Monitor adherence to antipsychotic medication;
whether taken in adequate dose and for correct
duration</li>
<li>If psychological treatments are prescribed,
review if the patient adheres to the treatment
or not and if the treatment techniques are
according to the prescribed guidelines or not.
Suggest cognitive behavioral therapy (CBT)
as an alternative for people who were advised
family intervention. If family intervention
was advised, then prefer CBT especially in
patients who are in close contact with their
families</li>
<li>Search for any other causes of nonresponse,
such as comorbid substance misuse (including
alcohol), comedication, and physical illness</li>
<li>Offer clozapine in patients whose illness
has not responded adequately even after
administering adequate doses of at least
2 different antipsychotic drugs, 1 of them
being a nonclozapine second-generation
antipsychotic.</li>
<li>If a patient is not responding adequately to
an adequate dose of clozapine, then consider
revisiting points I–IV. Then add a second
antipsychotic to augment treatment with
clozapine. The augmentation therapy may need
up to 8–10 weeks. The second antipsychotic
selected should not compound the common
side effects of clozapine.</li>
</ol>
<p><strong><br>
  Clinical evidence</strong></p>
Summary from 18 RCTs found that clozapine
was the more effective drug than first-generation
antipsychotics in patients with treatment-resistant
schizophrenia. Among second-generation
antipsychotics, more evidences are necessary
to establish equivalence between clozapine
and any other second-generation antipsychotic.
Further, limited data are available to establish
differences between any other antipsychotic
drugs. Among 10 RCTs examining the efficacy
of antipsychotics for negative symptoms, no
RCT reported significant clinical differences
between the different antipsychotics assessed.
However, recommendations suggest that careful
clinical assessment is necessary to identify
reasons for resistance such as drug-induced
parkinsonism, depressive features or certain
positive symptoms. Evidence from 6 RCTs
(n=252) showed that clozapine augmentation
with another antipsychotic might improve both
total and negative symptoms if administered for
an adequate duration.
<li style="list-style-type:square; color:#007945; font-size:16px"><a href="GDL-IIf.html">Treatment with depot/longacting
injectable antipsychotics</a></li>
<li style="list-style-type:square; color:#007945; font-size:16px"><a href="GDL-IIg.html">Maintenance therapy</a></li>
</ul>
            
            
 </div>
 <div id="top8">
		<section>
		  <div class="heading">
			<div class="content">
				<ul> <li><a href="GDL-I.html">Introduction
                </a></li>
 <li style="color:#CCC">Recommendations</li>
             <li><a href="GDL-III.html">Conclusion</a></li>
             <li><a href="GDL-IV.html">Source</a></li>

</ul>
                </div></section></div>
		</article>
	</div>
	<div id="sidebar">
		<section>
		  <div class="heading">
	    <h2>Content</h2></div>
			<div class="content">
				<ul>
					<li><a href="Amisulpride.html">Amisulpride</a></li>
					<li><a href="DER.html">Divalproex extended release</a></li>
					<li><a href="MBD.html">MetS with bipolar disorder</a></li>
					<li><a href="EP.html">Escitalopram</a></li>
					<li><a href="ZER.html">Zolpidem extended release</a></li>
					<li><a href="SCL.html">Scales</a></li>
                    <li><a href="GDL.html">Guidelines</a></li>
                    <li><a href="JC.html">Journal scans</a></li>
                    <li><a href="CN.html">Conference news</a></li>
                  <li><a href="PMS.html">Psychiatry medical app</a></li>
                    <li><a href="BR.html">Book review</a></li>
				</ul>
			</div>
		</section>
		<section>
			<div class="heading"><h2>Archives</h2></div>
			<div class="content">
				<ul>
					<li><a href="#">September 2013</a></li>
					<li><a href="index.html">November 2013</a></li>
					<li><a href="#">January 2014</a></li>
				</ul>
			</div>
		</section>
	</div>
	<div class="clear"></div>
</section>
<!--------------Footer--------------->
<footer>
	<p>Copyright © 2013 Medekahealth.com - All rights reserved. | Design by: <a href="#" target="_blank">MedekaHealth.com</a></p>
</footer>
</body></html>